CPIXCumberland Pharmaceuticals Inc.
$6.48
$0.36
(5.26%)
Closed $6.48
$0.13
(2.01%)
After Hours
EarningsAug 4
Mkt Cap$102.48M
Vol38,883.00
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference PR Newswire NASHVILLE, Tenn., June 26, 2026...
PR Newswire
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement PR Newswire TEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 $6 million upfront with up to approximately $13.4 million of potential aggregate...
PR Newswire
RedHill Biopharma Announces Up To $19.4 Million Private Placement
RedHill Biopharma Announces Up To $19.4 Million Private Placement RedHill Biopharma Announces Up To $19.4 Million Private Placement PR Newswire TEL AVIV, Israel & RALEIGH, N.C., June 18, 2026 $6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the...
PR Newswire
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation PR Newswire RALEIGH, N.C. and...
PR Newswire
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, June 8, 2026 RALEIGH, N.C.and TEL-AVIV, Israel, June 8...
PR Newswire
Cumberland's Ifetroban Shows Potential to Limit Metastasis
CPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promising early signs of reducing cancer metastasis in high-risk patients.
Zacks
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis PR Newswire NASHVILLE, Tenn., June 2, 2026 Positive Results from Phase 2a...
PR Newswire
Cumberland Expands Global Reach With Vibativ Launch in China
CPIX launches Vibativ in China through SciClone, expanding access to its antibiotic treatment for serious Gram-positive bacterial infections.
Zacks
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV IN CHINA
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV IN CHINA CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV IN CHINA PR Newswire NASHVILLE, Tenn., May 28, 2026 Commercialization in China through partnership with SciClone PharmaceuticalsExpands access to potentially life-saving...
PR Newswire
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial
Alphabet, Apple and Micron lead Zacks analyst reports as AI demand and product cycles drive tech momentum.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
Latest CPIX News
ViewCumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
PR Newswire
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
PR Newswire
RedHill Biopharma Announces Up To $19.4 Million Private Placement
PR Newswire
Advertisement|Remove ads.